Accession Number: | 0001209191-20-038007 |
Date: | 2020-06-18 |
Issuer: | SPECTRUM PHARMACEUTICALS INC (SPPI) |
Original Submission Date: |
VYAS DOLATRAI
11500 S. EASTERN AVE.
SUITE 240
HENDERSON, NV 89052
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, $0.001 PAR VALUE | 2020-06-18 | A | 30,000 | a | $0.00 | 81,069 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.94 | 2020-06-18 | deemed execution date | A | 60,000 (a) | 2030-06-18 | common stock 60,000 | $2.94 | 60,000 | direct |
ID | footnote |
---|---|
f1 | 100% of the restricted shares shall vest on the earlier of (1) june 18, 2021 or (2) the date of the company's 2021 annual meeting of stockholders. |
f2 | one third of the aggregate amount of option shares shall vest on each of june 18, 2021, 2022 and 2023, respectively. |